<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03897530</url>
  </required_header>
  <id_info>
    <org_study_id>I 75418</org_study_id>
    <nct_id>NCT03897530</nct_id>
  </id_info>
  <brief_title>Experimental Tobacco Marketplace in Regulating Flavored Tobacco Products in Menthol Cigarette Smokers</brief_title>
  <official_title>Flavored Tobacco Product Regulation: Behavioral Economic Demand, Visual Attention, and Flavored Tobacco Product Availability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Roswell Park Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial uses an Experimental Tobacco Marketplace to study the purchase of tobacco products&#xD;
      in menthol cigarette smokers. Determining the level of substitutability of both flavored and&#xD;
      unflavored/tobacco flavored e-cigarettes when menthol cigarettes are available and&#xD;
      unavailable can help determine if a flavor ban (of either menthol cigarettes and/or flavored&#xD;
      e-cigarettes) will lead to smoking cessation and/or harm reduction. A greater understanding&#xD;
      of tobacco product purchasing could help inform possible regulatory actions by the Food and&#xD;
      Drug Administration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants view and purchase hypothetical tobacco products during four distinctly different&#xD;
      Experimental Tobacco Marketplace (ETM) conditions. During the session, participants are&#xD;
      presented with these randomly ordered conditions: menthol cigarettes and five flavored&#xD;
      e-cigarettes (menthol/mint, fruits, sweets, alcohol, snacks/meals), menthol cigarettes and&#xD;
      both unflavored and tobacco-flavored e-cigarettes, non-menthol cigarettes and five flavored&#xD;
      e-cigarettes, and non-menthol cigarettes and both unflavored and tobacco-flavored&#xD;
      e-cigarettes. Participants' visual attention is evaluated by eye-tracking equipment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cessation of Menthol flavored cigarettes</measure>
    <time_frame>At the time of the session , assessed up to 15 months</time_frame>
    <description>Number of flavored cigarettes purchased inThe Experimental Market Place (ETM) will be used to track tobacco purchase behaviors</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Eye tracking metrics</measure>
    <time_frame>At the time of the session , assessed up to 15 months</time_frame>
    <description>the interaction of type of cigarette available (menthol versus non-menthol) and type of e-cigarette available (flavors versus unflavored and tobacco), will employ a 2 X 2 repeated measures ANOVA with post-hoc Bonferroni tests to evaluate the outcomes of Q0 (derived initial consumption without cost constraints), Î± (demand elasticity), the substitution levels, and the eye-tracking metrics.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">206</enrollment>
  <condition>Cigarette Smoking</condition>
  <arm_group>
    <arm_group_label>Prevention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the session, participants are presented with randomly ordered conditions: menthol cigarettes and five flavored e-cigarettes (menthol/mint, fruits, sweets, alcohol, snacks/meals), menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes, non-menthol cigarettes and five flavored e-cigarettes, and non-menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes. Participants' visual attention is evaluated by eye-tracking equipment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Smoking Cessation Intervention</intervention_name>
    <description>View and purchase hypothetical tobacco products during four distinctly different ETM</description>
    <arm_group_label>Prevention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional Assessment</intervention_name>
    <description>Visual attention is evaluated via eye-tracking equipment</description>
    <arm_group_label>Prevention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Prevention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Menthol cigarette smokers who report smoking a brand that has a non-menthol&#xD;
             equivalent.&#xD;
&#xD;
          -  Residing in Western New York.&#xD;
&#xD;
          -  Voluntarily provide informed consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any known history of macular degeneration, glaucoma, cataracts, eye implant,&#xD;
             permanently dilated pupils or the use of a screen reader/magnifier.&#xD;
&#xD;
          -  The following special populations will not be included:&#xD;
&#xD;
               -  Adults unable to consent&#xD;
&#xD;
               -  Individuals who are not yet adults (infants, children, teenagers)&#xD;
&#xD;
               -  Prisoners&#xD;
&#xD;
               -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amanda Quisenberry</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roswell Park Cancer Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amanda Quisenberry</last_name>
    <phone>1-800-767-9355</phone>
    <email>Askroswell@roswellpark.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2019</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

